Journal article
Treatment to target in psoriatic arthritis with apremilast: probability of achieving targets and comprehensive control of disease manifestations
- Abstract:
-
Objective: To evaluate the probability of achieving Clinical Disease Activity for Psoriatic Arthritis (cDAPSA) treatment targets of remission (REM) or low disease activity (LDA) with apremilast based on disease activity categories and corresponding responses in arthritis and other domains of psoriatic arthritis (PsA) not included in cDAPSA.
Methods: Pooled PALACE 1‐3 analyses were performed. Probability analyses assessing the likelihood of achieving...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Funding
Bibliographic Details
- Publisher:
- Wiley Publisher's website
- Journal:
- Arthritis Care and Research Journal website
- Volume:
- 72
- Issue:
- 6
- Pages:
- 814-821
- Publication date:
- 2020-01-07
- Acceptance date:
- 2019-12-31
- DOI:
- EISSN:
-
2151-4658
- ISSN:
-
2151-464X
- Pmid:
-
31909868
Item Description
- Language:
- English
- Pubs id:
-
1083073
- Local pid:
- pubs:1083073
- Deposit date:
- 2020-02-11
Terms of use
- Copyright holder:
- Mease et al.
- Copyright date:
- 2020
- Rights statement:
- © 2020 The Authors. Arthritis Care & Research published by Wiley Periodicals, Inc. on behalf of American College of Rheumatology. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
If you are the owner of this record, you can report an update to it here: Report update to this record